Document is current
Any future updates will be listed below
-
Authors
Wahlin, Björn Engelbrekt
Ljungqvist, Maria
Falk, Ola
Rådman, Therese
Lindé, Sandra
Sonnevi, Kristina
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 6 May 2025
Accepted: 16 July 2025
First Online: 31 July 2025
Declarations
:
: This research was conducted in accordance with Ethic Approval No. 2012/783 − 31/3, with amendment 2019–06366 (Swedish Ethical Review Authority), and the requirement for written consent was waived by the review board, but all patients provided their consent for rituximab treatment. All research was conducted in accordance with the Helsinki declaration as revised in 2013 and its later amendments.
: The authors declare no competing interests.
: The authors have no conflicts of interest.
